GIFOF
Price
$8.28
Change
-$0.15 (-1.78%)
Updated
Nov 25 closing price
GRFS
Price
$7.55
Change
-$0.50 (-6.21%)
Updated
Dec 18, 04:17 PM (EDT)
71 days until earnings call
Ad is loading...

GIFOF vs GRFS

Header iconGIFOF vs GRFS Comparison
Open Charts GIFOF vs GRFSBanner chart's image
Grifols Sa
Price$8.28
Change-$0.15 (-1.78%)
Volume$340
CapitalizationN/A
Grifols SA
Price$7.55
Change-$0.50 (-6.21%)
Volume$200
CapitalizationN/A
GIFOF vs GRFS Comparison Chart
Loading...
GIFOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GRFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GIFOF vs. GRFS commentary
Dec 19, 2024

To understand the difference between Grifols SA - Ordinary Shares - Class B (Non-Voting) (GIFOF) vs. Grifols SA - ADR - Level III (GRFS) it is enough to know the definitions of Ordinary Shares - Class B and ADR - Level III

Ordinary Shares - Class B - Generally, Class B shares are issued by a company as a common stock with fewer voting rights and lower dividend priority than Class A shares. Class B may also have lower repayment priority in the event of a bankruptcy.

ADR - Level III - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars. Foreign companies issuing Level-III ADRs are mandated to fulfill all registration and reporting requirements imposed by the SEC. The security is allowed to be listed on a major U.S. stock exchange such as the New York Stock Exchange or the Nasdaq Stock Market. Unlike other types of ADR, Level-III ADRs can raise capital through a public offering within the United State.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (GIFOF: $8.28 vs. GRFS: $8.05)
Brand notoriety: GIFOF and GRFS are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GIFOF: 0% vs. GRFS: 114%
Market capitalization -- GIFOF: $8.78B vs. GRFS: $5.48B
GIFOF [@Pharmaceuticals: Major] is valued at $8.78B. GRFS’s [@Pharmaceuticals: Major] market capitalization is $5.48B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GIFOF’s FA Score shows that 1 FA rating(s) are green whileGRFS’s FA Score has 1 green FA rating(s).

  • GIFOF’s FA Score: 1 green, 4 red.
  • GRFS’s FA Score: 1 green, 4 red.
According to our system of comparison, both GIFOF and GRFS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GIFOF’s TA Score shows that 3 TA indicator(s) are bullish while GRFS’s TA Score has 5 bullish TA indicator(s).

  • GIFOF’s TA Score: 3 bullish, 1 bearish.
  • GRFS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, GIFOF is a better buy in the short-term than GRFS.

Price Growth

GIFOF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while GRFS (@Pharmaceuticals: Major) price change was +11.81% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -2.43%. For the same industry, the average monthly price growth was -3.05%, and the average quarterly price growth was -1.91%.

Reported Earning Dates

GRFS is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-2.43% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GIFOF($8.79B) has a higher market cap than GRFS($5.48B). GRFS has higher P/E ratio than GIFOF: GRFS (68.68) vs GIFOF (48.31). GIFOF YTD gains are higher at: -17.200 vs. GRFS (-30.363). GIFOF has higher annual earnings (EBITDA): 726M vs. GRFS (640M). GIFOF (557M) and GRFS (544M) have equal amount of cash in the bank . GIFOF (10.9B) and GRFS (11.1B) have identical debt. GRFS (6.54B) and GIFOF (6.46B) have equivalent revenues.
GIFOFGRFSGIFOF / GRFS
Capitalization8.79B5.48B160%
EBITDA726M640M113%
Gain YTD-17.200-30.36357%
P/E Ratio48.3168.6870%
Revenue6.46B6.54B99%
Total Cash557M544M102%
Total Debt10.9B11.1B98%
FUNDAMENTALS RATINGS
GIFOF vs GRFS: Fundamental Ratings
GIFOF
GRFS
OUTLOOK RATING
1..100
465
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
8
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8686
PRICE GROWTH RATING
1..100
5764
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GIFOF's Valuation (8) in the null industry is in the same range as GRFS (8) in the Pharmaceuticals Major industry. This means that GIFOF’s stock grew similarly to GRFS’s over the last 12 months.

GIFOF's Profit vs Risk Rating (100) in the null industry is in the same range as GRFS (100) in the Pharmaceuticals Major industry. This means that GIFOF’s stock grew similarly to GRFS’s over the last 12 months.

GIFOF's SMR Rating (86) in the null industry is in the same range as GRFS (86) in the Pharmaceuticals Major industry. This means that GIFOF’s stock grew similarly to GRFS’s over the last 12 months.

GIFOF's Price Growth Rating (57) in the null industry is in the same range as GRFS (64) in the Pharmaceuticals Major industry. This means that GIFOF’s stock grew similarly to GRFS’s over the last 12 months.

GIFOF's P/E Growth Rating (96) in the null industry is in the same range as GRFS (100) in the Pharmaceuticals Major industry. This means that GIFOF’s stock grew similarly to GRFS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GIFOFGRFS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
49%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
75%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
66%
Aroon
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
GIFOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GRFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTTUX58.83N/A
N/A
Goldman Sachs Small Cp Val Insghts R6
USPVX31.06-0.11
-0.35%
Union Street Partners Value A
LGMAX26.52-0.15
-0.56%
Loomis Sayles Global Allocation A
FTTEX11.75-0.08
-0.68%
Fidelity Advisor Total Intl Equity M
VISGX82.75-0.85
-1.02%
Vanguard Small Cap Growth Index Inv

GIFOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GIFOF has been loosely correlated with GRFS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GIFOF jumps, then GRFS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GIFOF
1D Price
Change %
GIFOF100%
N/A
GRFS - GIFOF
37%
Loosely correlated
+5.64%
GIFLF - GIFOF
32%
Poorly correlated
N/A
GIKLY - GIFOF
27%
Poorly correlated
+2.19%
AMRN - GIFOF
21%
Poorly correlated
-0.80%
BAYZF - GIFOF
12%
Poorly correlated
-0.51%
More

GRFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRFS has been closely correlated with GIKLY. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GRFS jumps, then GIKLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRFS
1D Price
Change %
GRFS100%
+5.64%
GIKLY - GRFS
68%
Closely correlated
+2.19%
GIFOF - GRFS
37%
Loosely correlated
N/A
PFE - GRFS
28%
Poorly correlated
+4.67%
GIFLF - GRFS
23%
Poorly correlated
N/A
AMGN - GRFS
21%
Poorly correlated
-0.21%
More